Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Pediatrics

Treating the Hemangioma

At a Glance

For children with PHACE syndrome, propranolol is often the first-line treatment for a complicated hemangioma, but doctors usually assess brain and heart blood vessels first and monitor dosing, feeding, blood sugar, and breathing closely.

The standard treatment for a “complicated” infantile hemangioma—one that is large, near a vital organ like the eye, or likely to cause scarring—is a medication called propranolol [1]. Propranolol is a beta-blocker, a type of medicine that has been used for decades to treat heart conditions, but it is now the first-line choice for shrinking hemangiomas [2].

Is Propranolol Safe for PHACE Syndrome?

Because PHACE syndrome can involve differences in the blood vessels of the brain and heart, parents often worry about using a medication that affects heart rate and blood pressure.

Research specifically looking at infants with PHACE from a small observational cohort is generally reassuring. In a large study of 76 children with PHACE who were treated with oral propranolol, there were no serious adverse events, such as strokes or heart attacks [1]. While the risk is not zero, and this does not prove it is entirely as safe as in children without PHACE, the study found that children with PHACE did not have more serious complications than children without the syndrome [1].

The primary theoretical concern is that if a child’s brain blood vessels are very narrow or missing, a sudden drop in blood pressure could reduce blood flow to the brain [3][4]. This is why doctors typically perform a full workup—including an MRI/MRA and a heart exam—before starting the medication [5][6]. However, if a hemangioma is urgently threatening the airway, vision, or another vital function, specialists may initiate supervised treatment while evaluation proceeds rather than delaying care.

Airway Risks and Emergency Signs

If the hemangioma is on the “beard” area (lower face/neck), it may involve the airway. Seek urgent care for stridor (noisy breathing), increased work of breathing, cyanosis (blueness), or inability to feed. Not every facial hemangioma involves the airway, but these signs warrant prompt assessment.

Monitoring Your Child During Treatment

When your child begins propranolol, the medical team will follow a careful, clinician-directed protocol to ensure they tolerate the medicine well. Common steps include:

  • Observation during the first dose: Your child may stay in the clinic or hospital for a few hours after the first dose to check their heart rate and blood pressure [7].
  • Low and slow dosing: Treatment usually starts at a low dose and is increased gradually over several weeks to reach the full “target” dose [8][3]. Do not adjust the dose based on home blood-pressure readings.
  • Feeding is key: To prevent hypoglycemia (low blood sugar), propranolol must always be given during or immediately after a full feeding [2][9]. If your child is sick, vomiting, or refusing to eat, you should generally skip the dose and call your doctor [9]. Never double a missed dose.
    • Warning Signs of Hypoglycemia: Unusual sleepiness, pallor, sweating, limpness, poor responsiveness, or seizure. Seek emergency care immediately.

Common but minor side effects can include changes in sleep patterns, cold hands or feet, or mild diarrhea [1][9]. Watch out for wheezing or bronchospasm, and follow your prescriber’s plan for respiratory illnesses.

Alternative Treatments

While propranolol is the most effective treatment, it may not be suitable for every child, or it may not work fully on its own. In these cases, doctors may consider:

  • Corticosteroids: These are powerful anti-inflammatory medicines. They may be used alongside propranolol if the hemangioma is very aggressive, though they are less commonly used as a first choice today because of side effects like irritability or high blood pressure [3].
  • Sirolimus: This is a newer medication sometimes used for very complex or rare types of hemangiomas that don’t respond to standard treatment, though evidence for its use specifically in PHACE is still limited to individual cases [10].
  • Laser Therapy: Once the hemangioma has finished shrinking, a laser (such as a pulsed-dye laser) can help remove any remaining redness or thin visible blood vessels on the skin [11][12].
  • Surgery: In rare cases, if a hemangioma is causing a direct blockage (like in the airway) or if there is significant extra skin left after it shrinks, surgery may be discussed [13][14].

Every child with PHACE has a unique “map” of blood vessels, so your medical team will tailor the treatment plan specifically to your child’s anatomy and needs [6].

Common questions in this guide

Is propranolol safe for a child with PHACE syndrome?
Propranolol is commonly used as the first treatment for a complicated infantile hemangioma. In an observational study of 76 children with PHACE treated with oral propranolol, no serious adverse events were reported, but the risk is not zero. Because PHACE can involve blood vessels in the brain and heart, specialists usually complete an evaluation and monitor treatment carefully.
What tests are needed before my child starts propranolol for PHACE syndrome?
Doctors commonly review the brain's blood vessels with MRI/MRA and assess the heart, often with a heart ultrasound. These results help the team decide how to start and monitor propranolol. If the hemangioma threatens the airway, vision, or another vital function, treatment may begin under specialist supervision while evaluation continues.
What happens when my child takes the first dose of propranolol?
The medical team may observe your child in a clinic or hospital for several hours and check heart rate and blood pressure. Treatment often starts at a low dose and increases gradually to the prescribed target. Do not change the dose based on home blood-pressure readings unless the prescribing team instructs you to do so.
How should propranolol be given when my child is sick?
Give propranolol during or immediately after a full feeding, following the prescribed schedule. If your child is vomiting, refusing food, or unable to take a full feed, generally skip the dose and call the prescribing team. Never give two doses to make up for one that was missed.
What symptoms mean my child needs emergency help during hemangioma treatment?
Stridor, increased work of breathing, blue color, or inability to feed can signal a serious airway problem and warrant urgent medical assessment. Severe low blood sugar can cause unusual sleepiness, paleness, sweating, limpness, poor responsiveness, or a seizure; seek emergency care immediately for these signs.
Does a facial hemangioma mean my child's airway is involved?
Not every facial hemangioma affects the airway, but lesions in the beard area of the lower face or neck can raise concern. Noisy breathing, increased work of breathing, blue color, or difficulty feeding should prompt urgent assessment.
What if propranolol does not work or cannot be used?
Depending on the hemangioma and the child's anatomy, specialists may consider corticosteroids or, in complex cases, sirolimus. Pulsed-dye laser can treat residual redness after the lesion shrinks, and surgery may be considered for airway blockage or significant leftover skin.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my child's MRI/MRA show any narrowing or missing blood vessels in the brain that might change how we use propranolol?
  2. 2.What is the specific monitoring plan for the first dose—will it be done in the hospital or at the clinic?
  3. 3.What is our specific written plan for sick days, vomiting, or if my child refuses to eat?
  4. 4.How do the findings from the echocardiogram (heart ultrasound) affect the target dose of propranolol?
  5. 5.If the hemangioma is near the eye or airway, does my child need more frequent monitoring by an eye or ENT specialist while on this treatment?
  6. 6.What should I do if my child gets a stomach virus or skips a meal while taking this medication?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome.

    Olsen GM, Hansen LM, Stefanko NS, et al.

    JAMA dermatology 2020; (156(2)):186-190 doi:10.1001/jamadermatol.2019.3839.

    PMID: 31825455
  2. 2

    Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review.

    Léaute-Labrèze C, Boccara O, Degrugillier-Chopinet C, et al.

    Pediatrics 2016; (138(4)).

    PMID: 27688361
  3. 3

    Propranolol and prednisolone combination for the treatment of segmental haemangioma in PHACES syndrome.

    Gnarra M, Solman L, Harper J, Batul Syed S

    The British journal of dermatology 2015; (173(1)):242-6 doi:10.1111/bjd.13588.

    PMID: 25639889
  4. 4

    Arterial Spin-Labeling Perfusion for PHACE Syndrome.

    Mamlouk MD, Vossough A, Caschera L, et al.

    AJNR. American journal of neuroradiology 2021; (42(1)):173-177 doi:10.3174/ajnr.A6871.

    PMID: 33214180
  5. 5

    PHACE Syndrome: A Rare Case.

    Taslicay CA, Dervisoglu E, Ciftci E, et al.

    Journal of pediatric genetics 2020; (9(1)):27-31 doi:10.1055/s-0039-1694705.

    PMID: 31976140
  6. 6

    Phace Syndrome in Children: Two Case Reports.

    Imrani K, El Haddad S, Allali N, Chat L

    Radiology case reports 2021; (16(12)):3882-3886 doi:10.1016/j.radcr.2021.09.023.

    PMID: 34703511
  7. 7

    Oral propranolol and its impact on vital signs in hospitalized pediatric patients for the Management of Infantile Hemangiomas.

    Rypka K, Bellefeuille G, Wendland Z, et al.

    Pediatric dermatology 2025; (42(2)):245-250 doi:10.1111/pde.15740.

    PMID: 39963769
  8. 8

    Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines.

    Solman L, Glover M, Beattie PE, et al.

    The British journal of dermatology 2018; (179(3)):582-589 doi:10.1111/bjd.16779.

    PMID: 29774538
  9. 9

    Use of propranolol in a remote region of rural Guatemala to treat a large facial infantile haemangioma.

    Goldberg V, Martinez B, Cnop K, Rohloff P

    BMJ case reports 2017; (2017()) doi:10.1136/bcr-2017-219782.

    PMID: 28512124
  10. 10

    Sirolimus for diffuse intestinal infantile hemangioma with PHACE features: systematic review.

    Kleinman EP, Blei F, Adams D, Greenberger S

    Pediatric research 2023; (93(6)):1470-1479 doi:10.1038/s41390-022-02325-z.

    PMID: 36180586
  11. 11

    Multicenter Study of Long-Term Outcomes and Quality of Life in PHACE Syndrome after Age 10.

    Braun M, Frieden IJ, Siegel DH, et al.

    The Journal of pediatrics 2024; (267()):113907 doi:10.1016/j.jpeds.2024.113907.

    PMID: 38218370
  12. 12

    Nd:YAG laser in association with pulsed dye laser for the treatment of PHACES syndrome.

    Negosanti F, Silvestri M, Bennardo L, et al.

    Dermatology reports 2021; (13(1)):8751 doi:10.4081/dr.2021.8751.

    PMID: 33824704
  13. 13

    PHACES Syndrome with Intestinal Hemangioma Causing Recurrent Intussusceptions: A Case Report and Literature Review of Associated Intestinal Hemangioma.

    Al-Musalhi B, Al-Balushi Z

    Oman medical journal 2020; (35(6)):e204 doi:10.5001/omj.2020.99.

    PMID: 33403127
  14. 14

    A Multimodal Approach to a Complex PHACES Patient With Progressive Infantile Hemangioma: A Case Report and Review of Literature.

    Hicks ED, Hameed M, Shahare H, et al.

    Cureus 2025; (17(3)):e80261 doi:10.7759/cureus.80261.

    PMID: 40196066

This page is for informational purposes only and does not constitute medical advice. Your child's vascular anomalies team should guide propranolol use, monitoring, and emergency care in PHACE syndrome.

Get notified when new evidence is published on PHACE syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.